eMedicine Specialties > Physical Medicine and Rehabilitation > Spinal Cord Injury

Brown-Sequard Syndrome: Treatment & Medication

Author: Carol Vandenakker-Albanese, MD, Director, Post-Polio Clinic, Department of Physical Medicine and Rehabilitation, University of California at Davis Health System; Physical Medicine and Rehabilitation Residency Director, University of California at Davis
Coauthor(s): Holly Zhao, MD, PhD, Assistant Professor of Clinical Physical Medicine and Rehabilitation, University of California Davis Health System
Contributor Information and Disclosures

Updated: Jul 31, 2008

Treatment

Rehabilitation Program

Physical Therapy

Physical therapy intervention starts in the acute care phase of treatment.11 Goals for therapy include the following:

  • Maintaining strength in neurologically intact muscles
  • Maintaining range of motion in joints
  • Preventing skin breakdown by proper positioning and weight shifting
  • Improving respiratory function by positioning and breathing exercises
  • Achieving early mobilization to increase tolerance of the upright position
  • Providing emotional and educational support for the patient and his/her family

As a person with SCI advances through acute rehabilitation, physical therapy addresses mobility issues. Functional movement starts with bed mobility, followed by transfers, wheelchair mobility, and in many cases of Brown-Séquard syndrome, ambulation. Appropriate equipment must be prescribed, and proper use of the equipment should be taught to the patient and caregivers. Prior to discharge, the patient's home is evaluated for accessibility and modifications, as well as for the need for adaptive equipment. The need for orthotics is assessed and recommended. After fitting, training with the device is vital to functional use. Patients and caregivers should be instructed in home exercise programs that are designed to maintain strength, flexibility, and balance.

Because neurologic recovery often continues following discharge from acute inpatient rehabilitation, physical therapy should continue in the outpatient setting. Frequent reassessments are indicated to set new functional goals and to modify treatment as needed.

Occupational Therapy

Occupational therapy is essential for regaining as much independence as possible in activities of daily living. Upper extremity function is assessed carefully and then is used to learn new techniques, with or without the use of adaptive equipment, for the performance of oral-facial hygiene, feeding, and dressing. Head control, upper extremity strength, and trunk balance are developed to enable the patient to accomplish these tasks. Transfers and wheelchair mobility are addressed in conjunction with the physical therapist. Driving assessment, adaptations, and training are performed when appropriate.

Patients with Brown-Séquard syndrome typically show neurologic improvement over the course of the first year after onset and may advance through several stages of independence in performing activities of daily living. Occupational therapy should be continued as long as the patient shows improvement in functional status.

Recreational Therapy

A person's leisure and recreational needs often increase after a significant change in physical function. Although patients with Brown-Séquard syndrome may regain more function than do most patients with SCI, recreational needs are important. Premorbid interests are assessed and incorporated into the development of adaptive sports, leisure activities, and a recreational program. The recreational therapist re-introduces a person with a disability into the community to develop the confidence needed for re-integration into society. The therapist also serves as a source of information and as a liaison to community programs for the disabled.

Medical Issues/Complications

Any SCI, regardless of degree of completeness, results in significant alterations of function of the respiratory, cardiovascular, digestive, urinary, musculoskeletal, and integumentary systems. Decreased pulmonary function, altered cardiovascular dynamics, neurogenic bowel and bladder dysfunctions, hypercalcemia, osteoporosis, heterotopic ossification, and insensate skin may not be avoidable, but secondary medical complications often are preventable with expert care. Secondary complications that need to be addressed with aggressive preventive measures and early treatment are:

  • Development of pulmonary infections and respiratory insufficiency
  • Uncontrolled autonomic dysreflexia
  • Bowel impaction
  • Urinary tract infections
  • Pressure ulcers
Avoidance of medical complications reduces morbidity and mortality; it also speeds the rehabilitation process.

Surgical Intervention

Surgical intervention in traumatic SCI has been controversial, focusing primarily on spinal stability.12,13 The need for prompt reduction of any spinal deformity is well accepted. The reduction can be achieved either posturally or operatively. Stabilization of the reduced spine to prevent further injury to the cord is more controversial. Stability may come from direct surgical repair with bone grafting and (often) instrumentation or from natural healing or autofusion in an orthosis. Most stable spinal injuries are treated nonoperatively, while unstable injuries are treated surgically. Surgical decompression of the spinal canal may be indicated for an incomplete syndrome in which residual compression is present.

Nontraumatic etiologies of Brown-S é quard syndrome usually involve mechanical compression or herniation of the spinal cord and require surgical decompression.9

Consultations

Acute consultations are based on patient symptomatology and the etiology of the Brown-Séquard syndrome. Although patients with Brown-Séquard syndrome frequently regain bladder function, consultation with a urologist is required most commonly for evaluation of neurogenic bladder dysfunction.14 Other specialists that should be available for consultation over the course of the patient's rehabilitation include the following:

  • Orthopedist
  • Neurosurgeon
  • General surgeon
  • Hematologist-oncologist
  • Infectious disease specialist
  • Pulmonologist
  • Cardiologist
  • Gastroenterologist
  • Neurologist
  • Psychiatrist
  • General medicine specialist
  • Dentist

Medication

The use of medications for Brown-Séquard syndrome is dependent on the etiology and acuity of onset. Acute treatment of traumatic SCI involves immediate dosing of methyl prednisolone. Acute immobility that is unrelated to a bleed requires anticoagulation therapy, if not contraindicated. GI protection is strongly recommended. Other medications are used to manage symptoms and complications as needed, including antibiotics, antispasmodics, pain medications, and laxatives. Full discussions of medications and other treatment options for the associated conditions can be found in articles on the specific medical complication.

Corticosteroids

These have anti-inflammatory properties and cause profound and varied metabolic effects. Corticosteroids modify the body's immune response to diverse stimuli.


Methylprednisolone (Adlone, Medrol, Solu-Medrol, Depo-Medrol, Depopred)

Decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reversing increased capillary permeability.

Adult

2-60 mg/d PO in 1-4 divided doses followed by gradual reduction to lowest level that maintains clinical response

Pediatric

0.5-1.7 mg/kg/d or 5-25 mg/m2/d PO/IV/IM divided q6-12h

Co-administration with digoxin may increase digitalis toxicity secondary to hypokalemia; estrogens may increase levels; phenobarbital, phenytoin, and rifampin may decrease levels (adjust dose); monitor patients for hypokalemia when taking concurrently with diuretics

Documented hypersensitivity; viral, fungal, or tubercular skin infections

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Hyperglycemia, edema, osteonecrosis, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, growth suppression, myopathy, and infections are possible complications of glucocorticoid use

More on Brown-Sequard Syndrome

Overview: Brown-Sequard Syndrome
Differential Diagnoses & Workup: Brown-Sequard Syndrome
Treatment & Medication: Brown-Sequard Syndrome
Follow-up: Brown-Sequard Syndrome
Multimedia: Brown-Sequard Syndrome
References

References

  1. McCarron MO, Flynn PA, Pang KA, et al. Traumatic Brown-Séquard-plus syndrome. Arch Neurol. Sep 2001;58(9):1470-2. [Medline][Full Text].

  2. Spinal Cord Injury Information Network. Facts and Figures at a Glance. 2008;[Full Text].

  3. McKinley W, Santos K, Meade M, et al. Incidence and outcomes of spinal cord injury clinical syndromes. J Spinal Cord Med. 2007;30(3):215-24. [Medline][Full Text].

  4. Hayes KC, Hsieh JT, Wolfe DL, et al. Classifying incomplete spinal cord injury syndromes: algorithms based on the International Standards for Neurological and Functional Classification of Spinal Cord Injury Patients. Arch Phys Med Rehabil. May 2000;81(5):644-52. [Medline].

  5. Moin H, Khalili HA. Brown Séquard syndrome due to cervical pen assault. J Clin Forensic Med. Apr 2006;13(3):144-5. [Medline].

  6. Chen PY, Lin CY, Tzaan WC, et al. Brown-Sequard syndrome caused by ossification of the ligamentum flavum. J Clin Neurosci. Sep 2007;14(9):887-90. [Medline].

  7. Clatterbuck RE, Belzberg AJ, Ducker TB. Intradural cervical disc herniation and Brown-Séquard's syndrome. Report of three cases and review of the literature. J Neurosurg. Apr 2000;92(2 Suppl):236-40. [Medline].

  8. Jacobsohn M, Semple P, Dunn R, et al. Stab injuries to the spinal cord: a retrospective study on clinical findings and magnetic resonance imaging changes. Neurosurgery. Dec 2007;61(6):1262-6; discussion 1266-7. [Medline].

  9. Parmar H, Park P, Brahma B, et al. Imaging of idiopathic spinal cord herniation. Radiographics. Mar-Apr 2008;28(2):511-8. [Medline].

  10. Miranda P, Gomez P, Alday R, et al. Brown-Sequard syndrome after blunt cervical spine trauma: clinical and radiological correlations. Eur Spine J. Aug 2007;16(8):1165-70. [Medline].

  11. Winchester PK, Williamson JW, Mitchell JH. Cardiovascular responses to static exercise in patients with Brown-Séquard syndrome. J Physiol. Aug 15 2000;527 Pt 1:193-202. [Medline][Full Text].

  12. Massicotte EM, Montanera W, Ross Fleming JF, et al. Idiopathic spinal cord herniation: report of eight cases and review of the literature. Spine. May 1 2002;27(9):E233-41. [Medline].

  13. Kohno M, Takahashi H, Yamakawa K, et al. Postoperative prognosis of Brown-Séquard-type myelopathy in patients with cervical lesions. Surg Neurol. Mar 1999;51(3):241-6. [Medline].

  14. Scivoletto G, Cosentino E, Morganti B, et al. Clinical prognostic factors for bladder function recovery of patients with spinal cord and cauda equina lesions. Disabil Rehabil. May 11 2007;1-8. [Medline].

  15. Pollard ME, Apple DF. Factors associated with improved neurologic outcomes in patients with incomplete tetraplegia. Spine. Jan 1 2003;28(1):33-9. [Medline].

  16. Little JW, Halar E. Temporal course of motor recovery after Brown-Sequard spinal cord injuries. Paraplegia. Feb 1985;23(1):39-46. [Medline].

  17. Antich PA, Sanjuan AC, Girvent FM, et al. High cervical disc herniation and Brown-Sequard syndrome. A case report and review of the literature. J Bone Joint Surg Br. May 1999;81(3):462-3. [Medline][Full Text].

  18. Blackwell TL, Krause JS, Winkler T, et al. Spinal Cord Injury Desk Reference: Guidelines for Life Care Planning and Case Management. New York, NY: Demos Medical Pub; 2001.

  19. Brugieres P, Malapert D, Adle-Biassette H, et al. Idiopathic spinal cord herniation: value of MR phase-contrast imaging. AJNR Am J Neuroradiol. May 1999;20(5):935-9. [Medline][Full Text].

  20. Cervical Spine Research Society, Editorial Committee. The Cervical Spine. 2nd ed. Philadelphia, Pa: Lippincott; 1989.

  21. Ellger T, Schul C, Heindel W, et al. Idiopathic spinal cord herniation causing progressive Brown-Séquard syndrome. Clin Neurol Neurosurg. Jun 2006;108(4):388-91. [Medline].

  22. Francis D, Batchelor P, Gates P. Posttraumatic spinal cord herniation. J Clin Neurosci. Jun 2006;13(5):582-6. [Medline].

  23. Gorman PH, Wuolle KS, Peckham PH, et al. Patient selection for an upper extremity neuroprosthesis in tetraplegic individuals. Spinal Cord. Sep 1997;35(9):569-73. [Medline].

  24. Hwang W, Ralph J, Marco E, et al. Incomplete Brown-Séquard syndrome after methamphetamine injection into the neck. Neurology. Jun 24 2003;60(12):2015-6. [Medline].

  25. Longo MJ, Jaffe CC. Images in clinical medicine. Electrical alternans. N Engl J Med. Dec 30 1999;341(27):2060. [Medline].

  26. Hochschuler SH, Cotler HB, Guyer RD, eds. Rehabilitation of the Spine: Science and Practice. St Louis, Mo: Mosby; 1993.

  27. Stover SL. Clinical Outcomes from the Model Systems. Gaithersburg, Md: Aspen Pubs; 1995.

  28. Tattersall R, Turner B. Brown-Séquard and his syndrome. Lancet. Jul 1 2000;356(9223):61-3. [Medline].

Further Reading

Keywords

Brown-Séquard syndrome, Brown-Séquard's syndrome, Brown-Séquard-plus syndrome, hemisection of the spinal cord, hemisection syndrome, partial spinal sensory syndrome

Contributor Information and Disclosures

Author

Carol Vandenakker-Albanese, MD, Director, Post-Polio Clinic, Department of Physical Medicine and Rehabilitation, University of California at Davis Health System; Physical Medicine and Rehabilitation Residency Director, University of California at Davis
Carol Vandenakker-Albanese, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, American College of Sports Medicine, American Medical Association, American Paraplegia Society, American Spinal Injury Association, Association of Academic Physiatrists, Florida Society of Physical Medicine and Rehabilitation, and Physiatric Association of Spine, Sports and Occupational Rehabilitation
Disclosure: Nothing to disclose.

Coauthor(s)

Holly Zhao, MD, PhD, Assistant Professor of Clinical Physical Medicine and Rehabilitation, University of California Davis Health System
Holly Zhao, MD, PhD is a member of the following medical societies: American Academy of Medical Acupuncture, American Academy of Physical Medicine and Rehabilitation, American Medical Association, and Association of Academic Physiatrists
Disclosure: Nothing to disclose.

Medical Editor

Elizabeth A Moberg-Wolff, MD, Associate Professor and Pediatric PM&R Fellowship Director, Department of Physical Medicine and Rehabilitation, Medical College of Wisconsin; Program Director, Tone Management and Mobility, Department of Physical Medicine and Rehabilitation, Children's Hospital of Wisconsin
Elizabeth A Moberg-Wolff, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine and American Academy of Physical Medicine and Rehabilitation
Disclosure: Medtronic Neurological Grant/research funds Speaking and teaching

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Michael T Andary, MD, MS, Residency Program Director, Professor, Department of Physical Medicine and Rehabilitation, Michigan State University College of Osteopathic Medicine
Michael T Andary, MD, MS is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, American Medical Association, and Association of Academic Physiatrists
Disclosure: allergan Honoraria Speaking and teaching

CME Editor

Kelly L Allen, MD, Consulting Staff, Department of Physical Medicine and Rehabilitation, Lourdes Regional Rehabilitation Center, Our Lady of Lourdes Medical Center
Disclosure: Nothing to disclose.

Chief Editor

Denise I Campagnolo, MD, MS, Director of Multiple Sclerosis Clinical Research and Staff Physiatrist, Barrow Neurology Clinics, St. Joseph's Hospital and Medical Center; Investigator for Barrow Neurology Clinics; Director, NARCOMS Project for Consort
Denise I Campagnolo, MD, MS is a member of the following medical societies: Alpha Omega Alpha, American Association of Neuromuscular and Electrodiagnostic Medicine, American Paraplegia Society, Association of Academic Physiatrists, and Consortium of Multiple Sclerosis Centers
Disclosure: Teva Neuroscience Honoraria Speaking and teaching; Serono-Pfizer Honoraria Speaking and teaching

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.